Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells

International Immunopharmacology

Volumn 8, Issue 4, 2008, Pages 542-547

  Yang, Yoolhee ^a   Paik, Jin Ho ^b   Cho, Daeho ^a   Cho, Jung Ah ^b   Kim, Chul Woo ^b  

^a Sookmyung Women's University   (South Korea)

^b Cancer Research Institute   (South Korea)

Author keywords

FoxP3; Regulatory T cell; Resveratrol; TGF

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; RESVERATROL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; DOSE RESPONSE; DOWN REGULATION; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR; TUMOR CELL;

ANIMALS; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; STILBENES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 39949083393     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.12.006     Document Type: Article

References (16)

1. Malmberg K.J. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?. Cancer Immunol Immunother 53 (2004) 879-892
2. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6 (2006) 295-307
3. + regulatory T cells. Int Immunol 16 (2004) 1643-1656
4. Chen M.L., Pittet M.J., Gorelik L., Flavell R.A., Weissleder R., von Boehmer H., et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc Natl Acad Sci USA 102 (2005) 419-424
5. Taieb J., Chaput N., Schartz N., Roux S., Novault S., Menard C., et al. Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. J Immunol 176 (2006) 2722-2729
6. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
7. Feng Y.H., Zhou W.L., Wu Q.L., Li X.Y., Zhao W.M., and Zou J.P. Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol Sin 23 (2002) 893-897
8. Zhou H.B., Chen J.J., Wang W.X., Cai J.T., and Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 11 (2005) 280-284
9. Wu S.L., Sun Z.J., Yu L., Meng K.W., Qin X.L., and Pan C.E. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 10 (2004) 3048-3052
10. Fulda S., and Debatin K.M. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23 (2004) 6702-6711
11. Tseng S.H., Lin S.M., Chen J.C., Su Y.H., Huang H.Y., Chen C.K., et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10 (2004) 2190-2202
12. Chen Y., Tseng S.H., Lai H.S., and Chen W.J. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136 (2004) 57-66
13. + regulatory T cells from human peripheral blood. J Immunol 166 (2001) 7282-7289
14. + regulatory T cell proliferation. J Exp Med 202 (2005) 919-929
15. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
16. Liu J.Y., Wu Y., Zhang X.S., Yang J.L., Li H.L., Mao Y.Q., et al. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine. Cancer Immunol Immunother 56 (2007) 1597-1604